Coronado Biosciences, Inc. announced that effective January 28, 2014, Dr. Kevin Hogan, the company's Chief Medical Officer, was separated from service from company. That same day, Board named current director, Mr. Weiss, Executive Vice Chairman, Strategic Development. Mr. Weiss has served as a director of the company since December 19, 2013 and from that time until January 27, 2014 served as the Co-Vice Chairman of the company's Board.

Mr. Weiss, age 47, is currently Co-Portfolio Manager and Partner of Opus Point Partners, LLC, which he joined in 2009. He also serves as Executive Chairman, Interim Chief Executive Officer and President of TG Therapeutics, Inc. since 2011.